基于多糖的炎症性微环境响应性纳米载体用于性结肠炎:设计,机制和治疗应用方面的进展
Si-Jie Wu1, Ran Feng1, Ran Meng1
1Engineering Research Center of Bio-process, Ministry of Education, Hefei University of Technology, 193 Tunxi Road, Hefei, Anhui, 230009, PR China; School of Food and Biological Engineering, Hefei University of Technology, 193 Tunxi Road, Hefei, Anhui, 230009, PR China.
基于多糖的炎症微环境响应纳米载体 (PIMRNs) 为性结肠炎 (UC) 治疗提供了一个有前途的新方法. 这些纳米载体准UCUC.
科学领域:
- 纳米技术纳米技术
- 材料科学 材料科学 材料科学
- 胃肠病学 胃肠病学
背景情况:
- 全球性结肠炎 (UC) 发病率正在上升,这对公众健康构成了重大挑战.
- 目前的UC疗法有效性有限,副作用很大.
- 纳米技术为UC管理提供了新的解决方案.
研究的目的:
- 审查基于多糖的炎症微环境响应纳米载体 (PIMRNs) 用于性结肠炎 (UC) 治疗.
- 要突出UC炎症微环境在PIMRN设计中的作用.
- 讨论PIMRN临床翻译的挑战和未来方向.
主要方法:
- 对治疗UC的PIMRNs近期进展的回顾.
- 分析PIMRN设计原则和优化策略.
- 讨论UC炎症微环境触发器 (ROS,pH,酶).
主要成果:
- PIMRNs表现出卓越的生物活性,生物相容性和多功能调制.
- PIMRNs能够实现由UC炎症微环境触发的有针对性,时空控制的药物释放.
- 这种响应性交付增强治疗效果,并最大限度地减少不良影响.
结论:
- PIMRNs代表了UC治疗策略的重大进步.
- 精确的向和PIMRNs的控制释放提供了更好的治疗结果.
- PIMRNs具有改变UC治疗和其他炎症疾病的潜力.
更多相关视频
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
相关概念视频
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
